The result in designing CAR-T cells to co-express CCR2b (the major isoform of the CCL2 chemokine receptor) showed that T cells homed to CCL2-expressing neuroblastoma and malignant pleural mesothelioma xenografts, respectively (60). This evidence concerns the gene CCL2 and neuroblastoma.